Topics

Glioblastoma | Treatment | Clinical trials | Anlotinib

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Anlotinib

Wu B, Zhang Z, Ma H, Huang J, Liu X, Shi L, Dong X, Lei D, Wang X, Zhang F, Zhao H, Lin H, Fu R, Zou Z, Qin Y, Wang H, Hu X, Yao D, Yang L, Yang J, Hong X, Wang J, Wen L, Zhang C, Liang Z, Yang Z, Nie X, Liu G, Hu F, Peng G, Jiang X, Yang K.
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O⁶-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
Cancer. 2026 Jun 24;132(13):e70502. doi: 10.1002/cncr.70502. PMID: 42339996. Trial registration ID: ChiCTR2000040116. ˍ